ELIXIR and Toxicology: a community in development
- PMID: 37842337
- PMCID: PMC10568213
- DOI: 10.12688/f1000research.74502.2
ELIXIR and Toxicology: a community in development
Abstract
Toxicology has been an active research field for many decades, with academic, industrial and government involvement. Modern omics and computational approaches are changing the field, from merely disease-specific observational models into target-specific predictive models. Traditionally, toxicology has strong links with other fields such as biology, chemistry, pharmacology and medicine. With the rise of synthetic and new engineered materials, alongside ongoing prioritisation needs in chemical risk assessment for existing chemicals, early predictive evaluations are becoming of utmost importance to both scientific and regulatory purposes. ELIXIR is an intergovernmental organisation that brings together life science resources from across Europe. To coordinate the linkage of various life science efforts around modern predictive toxicology, the establishment of a new ELIXIR Community is seen as instrumental. In the past few years, joint efforts, building on incidental overlap, have been piloted in the context of ELIXIR. For example, the EU-ToxRisk, diXa, HeCaToS, transQST, and the nanotoxicology community have worked with the ELIXIR TeSS, Bioschemas, and Compute Platforms and activities. In 2018, a core group of interested parties wrote a proposal, outlining a sketch of what this new ELIXIR Toxicology Community would look like. A recent workshop (held September 30th to October 1st, 2020) extended this into an ELIXIR Toxicology roadmap and a shortlist of limited investment-high gain collaborations to give body to this new community. This Whitepaper outlines the results of these efforts and defines our vision of the ELIXIR Toxicology Community and how it complements other ELIXIR activities.
Keywords: ELIXIR; FAIR; Toxicology; interoperability.
Copyright: © 2023 Martens M et al.
Conflict of interest statement
No competing interests were disclosed.
Similar articles
-
A community proposal to integrate structural bioinformatics activities in ELIXIR (3D-Bioinfo Community).F1000Res. 2020 Apr 22;9:ELIXIR-278. doi: 10.12688/f1000research.20559.1. eCollection 2020. F1000Res. 2020. PMID: 32566135 Free PMC article.
-
The future of metabolomics in ELIXIR.F1000Res. 2017 Sep 6;6:ELIXIR-1649. doi: 10.12688/f1000research.12342.2. eCollection 2017. F1000Res. 2017. PMID: 29043062 Free PMC article.
-
Systems Biology in ELIXIR: modelling in the spotlight.F1000Res. 2022 Nov 7;11:ELIXIR-1265. doi: 10.12688/f1000research.126734.2. eCollection 2022. F1000Res. 2022. PMID: 36742342 Free PMC article.
-
Information extraction in the life sciences: perspectives for medicinal chemistry, pharmacology and toxicology.Curr Top Med Chem. 2005;5(8):785-96. doi: 10.2174/1568026054637692. Curr Top Med Chem. 2005. PMID: 16101418 Review.
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
Cited by
-
Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps.Front Toxicol. 2024 Mar 8;6:1285768. doi: 10.3389/ftox.2024.1285768. eCollection 2024. Front Toxicol. 2024. PMID: 38523647 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous